Anakinra for the treatment of rheumatoid arthritis: a safety evaluation

Taylor and Francis Group, Expert Opinion on Drug Safety, 7(17), p. 727-732, 2018

Journal article published in 2018 by Julio Ramírez, Juan D. Cañete

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by